New pill shows promise for treating pancreatic cancer
Researchers report a new drug helped stop tumours growing in 90% of patients during a recent clinical trial.
Cancer Research UK described the findings as the biggest leap forward in decades for those suffering from this difficult disease. Dr Sam Godfrey stated that the results were incredibly exciting for the medical community.
The treatment works by shutting off specific mutations found in most pancreatic cancers that drive rapid tumour growth and spread. Doctors hope this new approach might extend patient life spans without guaranteeing a permanent end to the illness.
In the study, slightly more than 60% of individuals saw their tumours reduce in size or vanish completely after taking the medication. Some patients experienced undetectable tumours on scans while others saw their cancer stop growing entirely.
Further research is now needed to determine if these conditions can enter remission and how long that state will last. Experts believe the drug might also help treat other cancers like lung and ovarian types too soon.
This development offers significant hope for patients who previously had very low survival rates and limited treatment options available today. The results suggest a potential path toward longer survival times and improved quality of life for many.
“What this new drug has done is it's found a way of drugging the undruggable.”

